Valiant Laboratories’ shares are scheduled to debut on the bourses today. And, ahead of its listing Valiant Laboratories’ shares’ GMP rose 14.29%. The IPO was subscribed 29.76 times. The Qualified Institutional Buyers (QIBs) category was subscribed 20.83 times, the portion for non-institutional investors received a 73.64-time subscription, and the Retail Individual Investors (RIIs) quota got subscribed by 16.06 times.
Also Read
“The IPO was well-received by investors, with a subscription rate of 29.76 times. The current GMP is also favorable, indicating a listing premium of over 15%. Valiant Laboratories’ financial performance has been improving in recent years, and the company plans to expand further. The IPO valuation was also considered fair,” said Shivani Nyati, Head of Wealth, Swastika Investmart.
“However, there are some concerns as…